The US Supreme Court ruled yesterday, June 4, that pharmaceutical company Hikma’s generic cardiovascular drug does not infringe global biopharmaceutical company Amarin’s patents covering its drug ...

Treatment sequencing in advanced gastroenteropancreatic neuroendocrine tumours (GEP-NETs) remains a major unmet clinical need ...

WASHINGTON, June 4 (Reuters) - Drugmaker Hikma's (HIK.L), opens new tab generic version of Amarin Pharma's (AMRN.O), opens new tab cardiovascular medication Vascepa did not infringe Amarin's patents, ...

The Java Community Process formally launches development of Java SE 28, with Project Valhalla once again positioned as the release's most closely watched feature.

US Supreme Court Backs Generic Drugmaker in 'Skinny Label' Patent Case By Blake Brittain WASHINGTON, June 4 (Reuters) - Drugmaker Hikma's generic version of Amarin Pharma's cardiovascular medication ...

Drugmaker Hikma’s generic version of Irish-American company Amarin Pharma’s cardiovascular medication Vascepa did not infringe ‌Amarin’s patents, the US supreme court ruled on Thursday in a decision ...

(SOA) — What began as warnings from a handful of scientists, whistleblowers and patients has now become the subject of ongoing congressional scrutiny. In the fifth major hearing in the past year, ...

Compare AssemblyAI, OpenAI, Deepgram and ElevenLabs voice agent APIs on accuracy, pricing, latency, languages and production ...